1. Home
  2. INLX vs HOWL Comparison

INLX vs HOWL Comparison

Compare INLX & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • HOWL
  • Stock Information
  • Founded
  • INLX 1996
  • HOWL 2017
  • Country
  • INLX United States
  • HOWL United States
  • Employees
  • INLX N/A
  • HOWL N/A
  • Industry
  • INLX EDP Services
  • HOWL Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • HOWL Health Care
  • Exchange
  • INLX Nasdaq
  • HOWL Nasdaq
  • Market Cap
  • INLX 40.8M
  • HOWL 47.1M
  • IPO Year
  • INLX N/A
  • HOWL 2021
  • Fundamental
  • Price
  • INLX $9.87
  • HOWL $1.33
  • Analyst Decision
  • INLX
  • HOWL Strong Buy
  • Analyst Count
  • INLX 0
  • HOWL 5
  • Target Price
  • INLX N/A
  • HOWL $7.20
  • AVG Volume (30 Days)
  • INLX 2.3K
  • HOWL 135.4K
  • Earning Date
  • INLX 08-13-2025
  • HOWL 08-14-2025
  • Dividend Yield
  • INLX N/A
  • HOWL N/A
  • EPS Growth
  • INLX N/A
  • HOWL N/A
  • EPS
  • INLX N/A
  • HOWL N/A
  • Revenue
  • INLX $17,127,854.00
  • HOWL N/A
  • Revenue This Year
  • INLX $2.47
  • HOWL N/A
  • Revenue Next Year
  • INLX $7.72
  • HOWL N/A
  • P/E Ratio
  • INLX N/A
  • HOWL N/A
  • Revenue Growth
  • INLX N/A
  • HOWL N/A
  • 52 Week Low
  • INLX $8.74
  • HOWL $0.60
  • 52 Week High
  • INLX $16.50
  • HOWL $4.18
  • Technical
  • Relative Strength Index (RSI)
  • INLX 38.26
  • HOWL 55.49
  • Support Level
  • INLX $8.98
  • HOWL $1.20
  • Resistance Level
  • INLX $10.17
  • HOWL $1.40
  • Average True Range (ATR)
  • INLX 0.42
  • HOWL 0.08
  • MACD
  • INLX 0.01
  • HOWL 0.01
  • Stochastic Oscillator
  • INLX 40.16
  • HOWL 72.41

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: